Janssen Austria

Products and services

Cardiovascular and metabolic disorders
Through our pharmaceutical research and development efforts, we are developing innovative solutions and medications that can help people around the world living with diabetes, obesity, thrombosis and other chronic and potentially life-threatening conditions.

Immunology
Building upon our long-standing commitment to immunology, we continue to deliver new options to combat complex conditions, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease and psoriasis. Our rich heritage of innovation in biological research and medicines has allowed us to expand to oral and inhaled medicines for immunologic and pulmonary diseases.

Infectious diseases and vaccines
With a goal to improve public health by fighting infectious diseases worldwide, we are dedicated to delivering treatments for people living with HIV/AIDS, hepatitis C, tuberculosis, and other infectious diseases. Recently, we entered the field of prevention with the acquisition of Crucell, a company that develops vaccines and antibodies. As a result, we have a number of marketed vaccines and have furthered our pipeline based on Crucell’s unique technologies.

Neuroscience
With a longstanding, continued commitment to neuroscience, our vision is to reduce the burden, disability and devastation caused by serious neuropsychiatric diseases and pain conditions and restore hope for patients. Our areas of focus include: Neurology, which includes Alzheimer’s disease; psychiatry, focused on mood disorders, such as bipolar disease and major depressive disorder, and schizophrenia; and pain, where we have particular interest in chronic pain states and neuropathic pain.

Oncology
Through groundbreaking research and innovative partnerships, we aim to transform cancer into a preventable, chronic or curable disease. Our goal is to deliver diagnostic and therapeutic options that prolong and improve patients’ lives. We are focused on key cancer types, including ovarian cancer, hematologic malignancies, prostate cancer and lung cancers. We are dedicated to helping realize the promise of winning the “war on cancer.”